These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 16532107)
1. The treatment of masseter hypertrophy with botulinum toxin type A. Al-Ahmad HT; Al-Qudah MA Saudi Med J; 2006 Mar; 27(3):397-400. PubMed ID: 16532107 [TBL] [Abstract][Full Text] [Related]
2. The medical management of masseteric hypertrophy with botulinum toxin. Finn S; Ryan P; Sleeman D J Ir Dent Assoc; 2000; 46(3):84-6. PubMed ID: 11323940 [TBL] [Abstract][Full Text] [Related]
3. [Botulinum toxin type A treatment of cosmetically disturbing masseteric hypertrophy]. Rijsdijk BA; van ES RJ; Zonneveld FW; Steenks MH; Koole R Ned Tijdschr Geneeskd; 1998 Mar; 142(10):529-32. PubMed ID: 9623101 [TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin as an alternative for the treatment of aesthetic deformities. Barbosa MV; Nahas FX; Ferreira LM; Al-Ahmad HT; Al-Qudah M Saudi Med J; 2006 Oct; 27(10):1613; author reply 1613. PubMed ID: 17013500 [No Abstract] [Full Text] [Related]
5. Lower facial contouring with botulinum toxin type A. Tartaro G; Rauso R; Santagata M; Santillo V; Itro A J Craniofac Surg; 2008 Nov; 19(6):1613-7. PubMed ID: 19098563 [TBL] [Abstract][Full Text] [Related]
6. Treatment of unilateral masseter hypertrophy with botulinum toxin in two cases. Işeri M; Işeri PK Kulak Burun Bogaz Ihtis Derg; 2004; 12(3-4):99-102. PubMed ID: 16010109 [TBL] [Abstract][Full Text] [Related]
7. Treatment of masseteric hypertrophy with botulinum toxin: a report of two cases. Baş B; Ozan B; Muğlali M; Celebi N Med Oral Patol Oral Cir Bucal; 2010 Jul; 15(4):e649-52. PubMed ID: 20173718 [TBL] [Abstract][Full Text] [Related]
8. Effect of botulinum toxin type A injection into human masseter muscle on stimulated parotid saliva flow rate. Kwon JS; Kim ST; Jeon YM; Choi JH Int J Oral Maxillofac Surg; 2009 Apr; 38(4):316-20. PubMed ID: 19231136 [TBL] [Abstract][Full Text] [Related]
9. Intramuscular nerve distribution of the masseter muscle as a basis for botulinum toxin injection. Kim DH; Hong HS; Won SY; Kim HJ; Hu KS; Choi JH; Kim HJ J Craniofac Surg; 2010 Mar; 21(2):588-91. PubMed ID: 20489458 [TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin for masseter hypertrophy. Al-Muharraqi MA; Fedorowicz Z; Al Bareeq J; Al Bareeq R; Nasser M Cochrane Database Syst Rev; 2009 Jan; (1):CD007510. PubMed ID: 19160335 [TBL] [Abstract][Full Text] [Related]
11. Bruxism secondary to brain injury treated with botulinum toxin-A: a case report. El Maaytah M; Jerjes W; Upile T; Swinson B; Hopper C; Ayliffe P Head Face Med; 2006 Nov; 2():41. PubMed ID: 17123443 [TBL] [Abstract][Full Text] [Related]
13. The use of botulinum toxin for the treatment of temporomandibular disorder. Freund B; Schwartz M Oral Health; 1998 Feb; 88(2):32-7. PubMed ID: 9610334 [No Abstract] [Full Text] [Related]
14. The topographic anatomy of the masseteric nerve: A cadaveric study with an emphasis on the effective zone of botulinum toxin A injections in masseter. Kaya B; Apaydin N; Loukas M; Tubbs RS J Plast Reconstr Aesthet Surg; 2014 Dec; 67(12):1663-8. PubMed ID: 25175271 [TBL] [Abstract][Full Text] [Related]
15. Botox facial slimming/facial sculpting: the role of botulinum toxin-A in the treatment of hypertrophic masseteric muscle and parotid enlargement to narrow the lower facial width. Wu WT Facial Plast Surg Clin North Am; 2010 Feb; 18(1):133-40. PubMed ID: 20206096 [TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin A treatment for contouring of the lower leg. Han KH; Joo YH; Moon SE; Kim KH J Dermatolog Treat; 2006; 17(4):250-4. PubMed ID: 16971324 [TBL] [Abstract][Full Text] [Related]
17. Effects on craniofacial growth and development of unilateral botulinum neurotoxin injection into the masseter muscle. Tsai CY; Chiu WC; Liao YH; Tsai CM Am J Orthod Dentofacial Orthop; 2009 Feb; 135(2):142.e1-6; discussion 142-3. PubMed ID: 19201315 [TBL] [Abstract][Full Text] [Related]
18. [Advances in botulinum toxin applications]. Zaleski P Pol Merkur Lekarski; 1999 Sep; 7(39):134-7. PubMed ID: 10598494 [TBL] [Abstract][Full Text] [Related]
19. Commentary. De Almeida AR Dermatol Surg; 2009 Dec; 35(12):1907. PubMed ID: 20050146 [No Abstract] [Full Text] [Related]
20. Botulism toxin: use in disorders of the temporomandibular joint. Chang H Dent Today; 2005 Dec; 24(12):48, 50-1; quiz 51. PubMed ID: 16396158 [No Abstract] [Full Text] [Related] [Next] [New Search]